Skip to main content

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in MYGN — Myriad Genetics Inc

CIK 884546 SAN FRANCISCO, CA

Position in MYGN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$8,106,651
-$2,678,671 QoQ
Shares Held
1,801,478
+2.7% QoQ
Ownership
1.91%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MYGN Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $4,743,797,769 across 32 Diagnostics & Research names. MYGN ranks #25 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in MYGN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $8,106,651 1,801,478
2025-12-31 $10,785,322 1,753,711
2025-09-30 $12,138,447 1,678,900
2025-06-30 $7,094,319 1,336,030
2025-03-31 $10,337,053 1,165,395
2024-12-31 $15,431,084 1,125,535
2024-09-30 $29,671,641 1,083,302
2024-06-30 $25,485,558 1,041,928
2024-03-31 $21,031,455 986,466
2023-12-31 $17,726,683 926,159
2023-09-30 $14,192,288 884,806
2023-06-30 $19,938,068 860,141
2023-03-31 $20,226,779 870,718
2022-12-31 $12,197,599 840,634
2022-09-30 $15,951,814 836,049
2022-06-30 $14,802,517 814,668
2022-03-31 $20,415,049 810,121
2021-12-31 $21,879,375 792,731
2021-09-30 $25,828,577 799,894
2021-06-30 $25,551,424 835,560
2021-03-31 $24,983,555 820,478
2020-12-31 $16,544,939 836,871
2020-09-30 $10,468,955 802,834
2020-06-30 $9,060,716 799,005
2020-03-31 $11,837,990 827,253